Metastatic renal cell cancer: Major response to oxaliplatin, 5-fluorouracil, L-folinic acid (FOL-FOX) combination

被引：0
作者：
Chauffert, B [1 ]
Bonnotte, B [1 ]
Chvetzoff, G [1 ]
Flesch, M [1 ]
机构：
[1] CHU Dijon, Serv Med Interne Immunol Clin & Oncol, F-21034 Dijon, France
来源：
PRESSE MEDICALE | 1998年 / 27卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：859 / 859
页数：1
相关论文
共 50 条
[31]   Does polychemotherapy with 5-fluorouracil, methotrexate, and L-folinic acid influence the selenium, zinc, and copper serum levels in cancer of digestive tract? [J].
Iodice, P ;
Federico, A ;
Federico, P ;
Del Rio, A ;
Mellone, MC ;
Federico, P ;
Catalano, G .
JOURNAL OF TRACE ELEMENTS IN EXPERIMENTAL MEDICINE, 2001, 14 (01) :73-79
[32]   Comparison of a 48-hour infusion of 5-fluorouracil without folinic acid with 24-hour folinic acid/5-fluorouracil in patients with metastatic colorectal cancer refractory to bolus folinic acid/5-fluorouracil - A prospective cohort study [J].
Moehler, M ;
Gutzler, F ;
Steinmann, S ;
Boehme, M ;
Raeth, U ;
Stremmel, W ;
Galle, PR ;
Rudi, J .
CHEMOTHERAPY, 2003, 49 (1-2) :85-89
[33]   Oxaliplatin with high-dose folinic acid and 5-fluorouracil 48 H infusion in pretreated metastatic colorectal cancer (CRC) [J].
deGramont, A ;
Vignoud, J ;
Tournigand, C ;
Louvet, C ;
Varette, C ;
Raymond, E ;
Krulik, M .
EUROPEAN JOURNAL OF CANCER, 1995, 31A :716-716
[34]   Identification of predictive markers of response to 5-Fluorouracil and oxaliplatin in metastatic colorectal cancer [J].
Allen, Wendy L. ;
Boyer, John ;
Coyle, Vicky ;
McCulla, Andrea ;
McLean, Estelle G. ;
Longley, Daniel B. ;
Johnston, Patrick G. .
CANCER RESEARCH, 2006, 66 (08)
[35]   Oxaliplatin in combination with 5-fluorouracil/leucovorin or capecitabine in elderly patients with metastatic colorectal cancer [J].
Arkenau, Hendrik-Tobias ;
Graeven, Ullrich ;
Kubicka, Stephan ;
Grothey, Axel ;
Englisch-Fritz, Christina ;
Kretzschmar, Albrecht ;
Greil, Richard ;
Freier, Werner ;
Seufferlein, Thomas ;
Hinke, Axel ;
Schmoll, Hans-Joachim ;
Schmiegel, Wolff ;
Porschen, Rainer .
CLINICAL COLORECTAL CANCER, 2008, 7 (01) :60-64
[36]   TREATMENT OF ADVANCED COLORECTAL-CANCER WITH FOLINIC ACID AND 5-FLUOROURACIL IN COMBINATION WITH CISPLATINUM [J].
SAGASTER, P ;
ESSL, R ;
TEICH, G ;
FRITZ, E ;
WASILEWSKI, M ;
UMEK, H ;
DUNSER, E ;
MASCHER, H ;
MICKSCHE, M .
EUROPEAN JOURNAL OF CANCER, 1994, 30A (09) :1250-1254
[37]   THE ROLE OF FOLINIC ACID IN COMBINATION WITH 5-FLUOROURACIL IN THE TREATMENT OF ADVANCED COLORECTAL-CANCER [J].
WILKE, H ;
HARSTRICK, A ;
SEEBER, S .
ONKOLOGIE, 1995, 18 (01) :65-67
[38]   Phase I study of ursodeoxycholic acid in combination with 5-fluorouracil, leucovorin, oxaliplatin, and bevacizumab for metastatic colorectal cancer [J].
Lai, Lily L. ;
Chiu, Ken ;
Lim, Dean ;
Chao, Joseph ;
Frankel, Paul Henry .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
[39]   Weekly oxaliplatin, high-dose folinic acid and 24h-5-fluorouracil (FUFOX) as salvage therapy in metastatic colorectal cancer patients pretreated with irinotecan and folinic acid/5-fluorouracil regimens [J].
Moehler, M ;
Hoffmann, T ;
Hildner, K ;
Siebler, J ;
Galle, PR ;
Heike, M .
ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2002, 40 (12) :957-964
[40]   Clinical and economic benefits of irinotecan in combination with 5-fluorouracil and folinic acid as first line treatment of metastatic colorectal cancer [J].
D Cunningham ;
S Falk ;
D Jackson .
British Journal of Cancer, 2002, 86 :1677-1683
12345